COVID-19 Updates
Conference Coverage
Alcohol-related liver disease severity increased during COVID-19 pandemic
Increased alcohol sales and disrupted services may have led to worse clinical outcomes.
Conference Coverage
Immune response detected in most IBD patients after COVID vaccines
Overall, similar levels of antibodies were seen across vaccine type, age group, and medication class, with the exception of corticosteroids.
From the Journals
2021 AGA Rapid Review and Guideline Update: Pre-endoscopy SARS-CoV-2 testing post vaccination
The new guideline eases requirements for testing as vaccinations are rolled out in the interest of minimizing delays in care.
From the Journals
COVID-19: New GI symptoms don’t raise death risk in IBD
International registry data show new onset of GI symptoms is common in IBD patients with COVID-19 regardless of IBD disease status.
From the AGA Journals
IBD: COVID-19 vaccination still effective in immunosuppressed
The study of more than 14,000 veterans with IBD showed no significant difference in Moderna vs. Pfizer vaccines’ effectiveness.
Latest News
AMA, 55 other groups urge health care vax mandate
“We must continue to address workers’ concerns, engage with marginalized populations, and work with trusted messengers to improve vaccine...
From the Journals
More post–COVID-19 GI symptoms: Malnutrition, weight loss
The study was prompted by clinical observations during follow-up of difficulty regaining weight and other concerns.
Conference Coverage
The pandemic hurt patients with liver disease in many ways
Conference Coverage
GI symptoms and chronic fatigue may persist months after COVID-19
Loose stools, somatization, and chronic fatigue risks increased at a mean of 5 months after SARS-CoV-2 infection, suggesting a common...
From the Journals
Most patients with chronic inflammatory diseases have sufficient response to COVID-19 vaccination
A preprint publication of a study of 133 people with chronic inflammatory disease and 53 controls shows that those with CID mount immune responses...